Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;259(1):173-91.
doi: 10.1111/imr.12173.

Once a Treg, always a Treg?

Affiliations
Review

Once a Treg, always a Treg?

Deepali V Sawant et al. Immunol Rev. 2014 May.

Abstract

Regulatory T cells (Tregs) prevail as a specialized cell lineage that has a central role in the dominant control of immunological tolerance and maintenance of immune homeostasis. Thymus-derived Tregs (tTregs) and their peripherally induced counterparts (pTregs) are imprinted with unique Forkhead box protein 3 (Foxp3)-dependent and independent transcriptional and epigenetic characteristics that bestows on them the ability to suppress disparate immunological and non-immunological challenges. Thus, unidirectional commitment and the predominant stability of this regulatory lineage is essential for their unwavering and robust suppressor function and has clinical implications for the use of Tregs as cellular therapy for various immune pathologies. However, recent studies have revealed considerable heterogeneity or plasticity in the Treg lineage, acquisition of alternative effector or hybrid fates, and promotion rather than suppression of inflammation in extreme contexts. In addition, the absolute stability of Tregs under all circumstances has been questioned. Since these observations challenge the safety and efficacy of human Treg therapy, the issue of Treg stability versus plasticity continues to be enthusiastically debated. In this review, we assess our current understanding of the defining features of Foxp3(+) Tregs, the intrinsic and extrinsic cues that guide development and commitment to the Treg lineage, and the phenotypic and functional heterogeneity that shapes the plasticity and stability of this critical regulatory population in inflammatory contexts.

Keywords: Foxp3; epigenetics; heterogeneity; plasticity; regulatory T cells; stability.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1. Plasticity of Tregs
(Left) Tregs differentiate in parallel to effector T cells in response to micro-environmental cues in the periphery. Thus, Tregs adopt distinct transcription factor, chemokine receptor and microRNA-signatures to suppress effector T cells. (Right top) Tregs primed in response to tissue-specific antigens express chemokine receptors guiding their migration to restrain immune responses in distinct tissues. (Right bottom) Tregs exhibit plasticity in their differential expression and usage of suppressor modules.
Fig. 2
Fig. 2. The three signal-hypothesis of Treg stability
Tregs in the periphery bear distinct intrinsic signatures (signal 1) based on their Foxp3 expression and epigenetic status, resulting in generation of stable bona fide, transient uncommitted and potential Tregs. The stability of these differentially committed Tregs in any given microenvironment is set by their intrinsic signature and the balance of two other signals – Stabilizing signals (signal 2) and Destabilizing signals (signal 3). Stabilizing signals include survival and growth factors, quiescence factors and remodeling factors, while destabilizing signals include pro-inflammatory cytokines and mediators that antagonize Treg fate. Thus, inflammatory scenario 1 is likely to tip the balance towards the destabilizing factors, resulting in loss of Treg stability. On the contrary, scenario 2 is likely to tip the balance towards the stabilizing factors, thus maintaining stable Treg lineage.

References

    1. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol. 2003;21:139–176. - PubMed
    1. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 2012;30:531–564. - PMC - PubMed
    1. Jiang H, Chess L. An integrated view of suppressor T cell subsets in immunoregulation. J Clin Invest. 2004;114:1198–1208. - PMC - PubMed
    1. Mann MK, Ray A, Basu S, Karp CL, Dittel BN. Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity. 2012;45:388–399. - PMC - PubMed
    1. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162–174. - PMC - PubMed

Publication types

MeSH terms

Substances